Viscerotropic disease and acute uveitis following yellow fever vaccination: a case report

BMC Infect Dis. 2020 Feb 10;20(1):116. doi: 10.1186/s12879-020-4838-x.

Abstract

Background: Yellow fever vaccine exists for over 80 years and is considered to be relatively safe. However, in rare cases it can produce serious neurotropic and viscerotropic complications. We report a case of a patient who presented both viscerotropic and neurological manifestations after yellow fever vaccination.

Case presentation: We describe the case of a 37 years old man who developed after the yellow fever vaccination a yellow fever vaccine-associated viscerotropic disease followed by acute uveitis. Prolonged detection of yellow fever RNA in blood and urine was consistent with yellow fever vaccine-associated adverse event. The final outcome was good, although with persistent fatigue over a few months.

Conclusions: Even if the yellow fever vaccine is relatively safe, physicians should be aware of its possible serious adverse effects.

Keywords: Uveitis; Yellow fever vaccine; Yellow fever vaccine-associated viscerotropic disease.

Publication types

  • Case Reports

MeSH terms

  • Acute Disease
  • Adult
  • Drug-Related Side Effects and Adverse Reactions / blood
  • Drug-Related Side Effects and Adverse Reactions / etiology*
  • Drug-Related Side Effects and Adverse Reactions / pathology
  • Drug-Related Side Effects and Adverse Reactions / urine
  • Fatigue / chemically induced
  • Humans
  • Male
  • RNA, Viral / blood
  • RNA, Viral / urine
  • Uveitis / chemically induced*
  • Vaccination / adverse effects*
  • Yellow Fever Vaccine / adverse effects*

Substances

  • RNA, Viral
  • Yellow Fever Vaccine